Pharmacokinetic drug–drug interactions between 1,4-dihydropyridine calcium channel blockers and statins: factors determining interaction strength and relevant clinical risk management

BACKGROUND: Coadministration of 1,4-dihydropyridine calcium channel blockers (DHP-CCBs) with statins (or 3-hydroxy-3-methylglutaryl-coenzyme A [HMG-CoA] reductase inhibitors) is common for patients with hypercholesterolemia and hypertension. To reduce the risk of myopathy, in 2011, the US Food and D...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zhou, Yi-Ting, Yu, Lu-Shan, Zeng, Su, Huang, Yu-Wen, Xu, Hui-Min, Zhou, Quan
Formato: Artigo
Lenguaje:Inglês
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3873236/
https://ncbi.nlm.nih.gov/pubmed/24379677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S55512
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares